glp-1 type 1 diabetes news Timeline of discovery and clinical development. (a) Key events in... GLP-1 drugs are all approved
Description
Worldwide, nearly 40% of adults are overweight and 13% are obese
Not approved for diagnostic, therapeutic, or medical applications
Among Medicare patients, 18% started with a GLP-1 while 24% used an SGLT2, reflecting the higher prevalence of cardiovascular conditions in seniors and the dual benefits SGLT2s provide in heart health
Plans start at $129
Read the full article: At the Heart of Hormonal Healthcare #Menopause #WeightLoss #GLP1 #ObesityMedicine #Women'sHealth #MenopauseCare #MetabolicHealth #HormoneHealth #WeightManagement #HealthyAgeing #EvidenceBasedMedicine #LifestyleMedicine #Dietitian #Healthcare #MidlifeHealth #MenopauseSupport #HormoneTherapy #Women'sWellbeing #TheMenopauseConsortium
GLP-1 medications interact with certain drugs, supplements, and substances that may reduce efficacy or increase side effects
